✦ LIBER ✦

Response to hepatitis B vaccine in Alaska Natives with chronic alcoholism compared with non-alcoholic control subjects

✍ Scribed by Brian J. McMahon; Karen Wainwright; Lisa Bulkow; Alan J. Parkinson; Mark Lindenbaum; Robert Wainwright; Claire Helminiak

Book ID: 115683182
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 514 KB
Volume: 88
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(90)90423-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity of the 23-valent pneumoco

Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaska native chronic alcoholics compared with nonalcoholic native and non-native controls

✍ Brian J. McMahon; Alan J. Parkinson; Lisa Bulkow; Michael Davidson; Karen Wainwr 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 757 KB

A multi-centre, double-blind, parallel-g

A multi-centre, double-blind, parallel-group comparative study to assess the efficacy and safety of a single dose of either Hepagene™ or Engerix®B in subjects with an inadequate response to previous vaccination with an S-containing hepatitis B vaccine

✍ A Williams; M Young 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Lymphoblastoid interferon alfa-n1 improv

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

✍ Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l